Navigation Links
DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Date:5/3/2012

CUPERTINO, Calif., May 3, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended March 31, 2012. Excluding the accelerated recognition of deferred revenue described below, DURECT's reported revenues would have been $5.8 million for the three months ended March 31, 2012 (as compared to $8.6 million for the same period in 2011) and reported net loss would have been $4.6 million for the three months ended March 31, 2012 (as compared to a net loss of $6.4 million for the same period in 2011).  Total revenues as reported under GAAP were $41.2 million and net income as reported under GAAP was $30.8 million for the three months ended March 31, 2012; these figures include the accelerated recognition of $35.4 million in deferred revenue associated with upfront fees previously received under terminated collaboration agreements.  This $35.4 million in revenue is non-recurring and has no cash flow impact for the quarter.

(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)At March 31, 2012, we had cash and investments of $26.4 million, compared to cash and investments of $30.8 million at December 31, 2011."This quarter was dominated by the POSIDUR™ clinical trial results and partnership terminations.  However, we continued to make progress with our development programs and we have recently reinforced the protection of our pipeline through 13 patent issuances and 2 patent allowances involving major and/or partnered programs that extend patent protection in large market jurisdictions to 2025 or beyond," stated James E. Brown, D.V.M., President and CEO of DURECT.  "In particular, we now have issued U.S. patents covering REMOXY® and our other ORADUR®-based opioid programs that extend to at least 2025 as well
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
2. DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call
3. DURECT to Participate in Upcoming Healthcare Conferences
4. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
5. DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
6. DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)
7. DURECT Corporation to Participate in Upcoming Healthcare Conferences
8. DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
9. DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call
10. DURECT to Present at the Jefferies Healthcare Conference
11. DURECT Announces Resignation of Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... DUBLIN , Aug. 20, 2014 Research ... Market Report of Pralmorelin" report to their offering. ... at providing comprehensive data on Pralmorelin globally and regionally ( ... North America , Latin America ... to Pralmorelin This report focuses on three primary ...
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Advanced Wound Care and Closure Market (Types, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... and closure market (types, applications, end user and ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for Coatings ... following Product Segments: Active Coatings, Protective Coatings, Optical ... comprehensive analytics for the US, Canada ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... CHANGCHUN, China and LOS ANGELES, Dec. 10 ... ("Yongxin" or,"the Company"), a leading pharmaceutical distributor and chain ... ended,September 30, 2009. , "While ... discretionary,spending, we expect as the economy continues to recover ...
... MINNEAPOLIS, Dec. 10 Uroplasty, Inc. (NYSE Amex: ... and markets innovative proprietary products to treat voiding dysfunctions, ... of its Urgent® PC Neuromodulation System that will be ... THE JOURNAL OF UROLOGY® . The Urgent PC System ...
Cached Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4
(Date:8/21/2014)... 21, 2014 The employees of ... in Washington Crossing, Pennsylvania on Thursday, August 7th to ... have been looking for different ways that Pharmica could ... Partner with Pharmica Consulting. “When we heard that we ... history, we jumped at the opportunity.” , Pharmica spent ...
(Date:8/21/2014)... Teen substance abuse is long been a ... rising numbers of young adults falling victim to a drug ... difference in the community, the new Troubled Teens Boca Raton ... seeking to overcome something like teenage alcohol abuse . ... find the best teen recovery facility to focus on achieving ...
(Date:8/21/2014)... Recently nominated as the Women’s Radio Network’s “Top Host”, KC ... man he is today. Growing up, KC was greatly influenced ... women, respecting them as professionals and individuals. Through his struggles to ... man who he had the pleasure of working very closely to ... will ring a bell to most of you who, like many ...
(Date:8/20/2014)... Most people think of donating food ... get overlooked for a variety of reasons—thus making these ... Understanding this need, Dr. Bryne Willey of AlignLife ... care center, wanted to heighten awareness of the need ... annual Thanksgiving in July food drive to collect non-perishable ...
(Date:8/20/2014)... 2014 Medical Alert Systems, http://www.medicalalert-systems.com/ ... of some of the most popular medical alert devices ... announce that it is now offering special deals and ... are on a fixed income but would like to ... as very welcome news. , As a company spokesperson ...
Breaking Medicine News(10 mins):Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2Health News:New Helpline Provides Hope for Troubled Teens in Boca Raton 2Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 3
... As the medical community searches for better vaccines and ... believes he has discovered a new approach to boosting ... Ph.D., found that the same molecules used in drugs ... immune system, pushing them to make antibodies for protection ...
... Harold C. Simmons Comprehensive Cancer Center at UT Southwestern ... an elite distinction held by only the top-tier cancer ... first medical center in North Texas to attain this ... top cancer centers in recognition of innovative research and ...
... HealthDay Reporter , WEDNESDAY, Aug. 4 (HealthDay News) -- ... public health officials in California are urging residents, particularly ... infants, to make sure they,re immunized for the highly ... also higher than last year in Michigan, South Carolina, ...
... the Canadian Institutes for Health Research (CIHR) announced its ... on the list and two of them were headed ... Michael Cusimano will lead a team studying traumatic brain ... hospital,s director of trauma, will examine rural Canadians, access ...
... article in the current issue of Deutsches rzteblatt ... A. Lagrze examines whether or not childhood screening for ... disorders can occur even in very young children and ... the only eye disorder for which ophthalmological screening is ...
... Amanda Gardner HealthDay Reporter , TUESDAY, Aug. 3 ... go to an emergency room with a violent injury and ... episodes, new research finds. The authors calculated that for ... one violent episode in the future. The study was ...
Cached Medicine News:Health News:UR discovers new way to boost vaccines, seeks patent 2Health News:UT Southwestern's cancer center earns National Cancer Institute designation 2Health News:UT Southwestern's cancer center earns National Cancer Institute designation 3Health News:Spread of Whooping Cough Raises Concern 2Health News:Spread of Whooping Cough Raises Concern 3Health News:St. Michael's receives prestigious grants to study trauma 2Health News:One Therapy Session in ER Can Cut Teen Violence 2Health News:One Therapy Session in ER Can Cut Teen Violence 3
... Autolet Impression is the advanced lancing device ... Owen Mumford. Autolet Impression features unique Comfort ... ultimate control and comfort when lancing. Comfort ... targeting the sensation and perception of pain. ...
... The Qwik-Let Elite has become ... sold models. This popularity is due ... features found in the design and ... this innovative device is priced for ...
... new Finnpipette Focus from Thermo Labsystems was ... performance. Advanced features such as the ... volume adjustment on microvolumes help to define ... channel pipettes. The new interchangeable handle plate ...
... Seven digital models cover the range from ... liquid fluently. Volume lock design prevents inadvertent ... the horizontal grip. Whole pipette is autoclavable ... ejector is all polypropylene. Suitable for one-handed ...
Medicine Products: